Description
Peracetylatedepigallocatechin-3-gallate(AcEGCG)isacloserelativeofepigallocatechin-3-gallate,acatechinfoundingreentea(Camelliasinensis).AcEGCGhasahigherbioavailABIlitythanitsparentcompoundandexhibitsanti-inflammatoryandanticancerchemotherapeuticactivityinvitroandinvivo.AcEGCGactivatesERK1/2signaling,inhibitsacetylationofhistoneH3K9,anddownregulatesPI3K/Akt/NF-κBsignalingtoinhibittumorgrowthinavarietyofcancer-focusedanimalmodels.
References
ChiouYS,SangS,ChengKH,etal.Peracetylated(-)-epigallocatechin-3-gallate(AcEGCG)potentlypreventsskincarcinogenesisbysuppressingthePKD1-dependentsignalingpathwayinCD34+skinstemcellsandskintumors.Carcinogenesis.2013Jun;34(6):1315-22.PMID:23385063.
ChiouYS,MaNJ,SangS,etal.Peracetylated(-)-epigallocatechin-3-gallate(AcEGCG)potentlysuppressesdextransulfatesodium-inducedcolitisandcolontumOrigenesisinmice.JAgricFoodChem.2012Apr4;60(13):3441-51.PMID:22409325.
LambertJD,SangS,HongJ,etal.Peracetylationasameansofenhancinginvitrobioactivityandbioavailabilityofepigallocatechin-3-gallate.DrugMetabDispos.2006Dec;34(12):2111-6.PMID:16997910.